Ryan Alvarado

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

M. Belvin, S. Seshagiri, B. Jaiswal, 2010, Nature.

693 APX601, a Novel TNFR2 antagonist antibody for cancer immunotherapy

Ryan Alvarado, Xiaodong Yang, George Huang, 2020, Journal for ImmunoTherapy of Cancer.

Abstract 5753: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

M. Belvin, S. Seshagiri, B. Jaiswal, 2010 .

Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics

G. Hatzivassiliou, Kyung Song, Daniel J. Anderson, 2011, PloS one.